Penumbra, Inc. (PEN)
323.10
+1.42
(+0.44%)
USD |
NYSE |
Aug 31, 16:00
323.27
+0.17
(+0.05%)
Pre-Market: 20:00
Penumbra Cash from Operations (TTM) : 277.80M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 277.80M |
| March 31, 2026 | 276.66M |
| December 31, 2025 | 238.66M |
| September 30, 2025 | 203.29M |
| June 30, 2025 | 201.49M |
| March 31, 2025 | 179.16M |
| December 31, 2024 | 168.48M |
| September 30, 2024 | 153.63M |
| June 30, 2024 | 128.01M |
| March 31, 2024 | 122.50M |
| December 31, 2023 | 97.33M |
| September 30, 2023 | 62.41M |
| June 30, 2023 | 18.66M |
| March 31, 2023 | -38.02M |
| December 31, 2022 | -55.66M |
| September 30, 2022 | -66.27M |
| June 30, 2022 | -16.91M |
| March 31, 2022 | 19.36M |
| December 31, 2021 | 9.502M |
| September 30, 2021 | 16.69M |
| June 30, 2021 | -23.31M |
| March 31, 2021 | -41.69M |
| Date | Value |
|---|---|
| December 31, 2020 | -33.24M |
| September 30, 2020 | -26.39M |
| June 30, 2020 | -0.792M |
| March 31, 2020 | 22.80M |
| December 31, 2019 | 26.65M |
| September 30, 2019 | 29.42M |
| June 30, 2019 | 17.81M |
| March 31, 2019 | 16.03M |
| December 31, 2018 | 28.81M |
| September 30, 2018 | 20.37M |
| June 30, 2018 | 20.68M |
| March 31, 2018 | 21.20M |
| December 31, 2017 | 12.69M |
| September 30, 2017 | 3.241M |
| June 30, 2017 | -1.781M |
| March 31, 2017 | -7.029M |
| December 31, 2016 | -12.81M |
| September 30, 2016 | -12.10M |
| June 30, 2016 | -22.13M |
| March 31, 2016 | -23.20M |
| December 31, 2015 | -22.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Boston Scientific Corp. | 4.529B |
| Globus Medical, Inc. | 910.39M |
| Teleflex, Inc. | 403.20M |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |